Filtrer efter Last updated date SelectEfterFørFrom - To Dato Slutdato Denne uge Denne måned Seneste uge Seneste måned Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationResearch and developmentMedicine shortagesBiosimilarsSMEAntimicrobial resistanceGovernanceBrexitQuality of medicinesCorporateGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate useCareersMedication errorParallel distributionPRIMEProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety Yes Efterlad dette felt tomt Filter Resultater (3800) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Efterlad dette felt tomt Increased fees coming into effect on 1 April 2012 30 marts 2012News European medicines regulators agree a common, Europe-wide approach for the identification of commercially confidential information and personal data 27 marts 2012Press release EU Clinical Trials Register information now available through WHO's International Clinical Trials Registry Platform 26 marts 2012News European Medicines Agency Management Board strengthens conflicts of interest policies and transparency 26 marts 2012Press releaseCorporate European Medicines Agency holds workshop on vaccines development against Schmallenberg virus 22 marts 2012NewsMedicines Astellas Pharma Europe B.V. withdraws its application for an extension of the indication for Qutenza (capsaicin) 20 marts 2012Press releaseHuman Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 12-15 March 2012 16 marts 2012NewsHuman European Medicines Agency issues recommendations for 2012/2013 seasonal flu vaccine composition 16 marts 2012NewsHumanMedicines European Medicines Agency recommends transfer of manufacturing sites for Caelyx and Ceplene 16 marts 2012Press releaseHumanMedicines European Medicines Agency confirms positive benefit-risk balance of Protelos / Osseor, but recommends new contraindications and revised warnings 16 marts 2012Press releaseHumanMedicines 1 … 252 253 254 255 256 Page 256 of 380 257 258 259 260 … 380
European medicines regulators agree a common, Europe-wide approach for the identification of commercially confidential information and personal data 27 marts 2012Press release
EU Clinical Trials Register information now available through WHO's International Clinical Trials Registry Platform 26 marts 2012News
European Medicines Agency Management Board strengthens conflicts of interest policies and transparency 26 marts 2012Press releaseCorporate
European Medicines Agency holds workshop on vaccines development against Schmallenberg virus 22 marts 2012NewsMedicines
Astellas Pharma Europe B.V. withdraws its application for an extension of the indication for Qutenza (capsaicin) 20 marts 2012Press releaseHuman
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 12-15 March 2012 16 marts 2012NewsHuman
European Medicines Agency issues recommendations for 2012/2013 seasonal flu vaccine composition 16 marts 2012NewsHumanMedicines
European Medicines Agency recommends transfer of manufacturing sites for Caelyx and Ceplene 16 marts 2012Press releaseHumanMedicines
European Medicines Agency confirms positive benefit-risk balance of Protelos / Osseor, but recommends new contraindications and revised warnings 16 marts 2012Press releaseHumanMedicines
